{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:18:56Z","timestamp":1783567136825,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pharma.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:54:30Z","timestamp":1643576070000},"page":"659-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride"],"prefix":"10.1016","volume":"80","author":[{"given":"Z.M.M.","family":"Omar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.-N.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"El-Bakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0325","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global Burden of Disease (GBD) for hepatitis C","volume":"44","author":"Hutin","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharma.2022.01.005_bib0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2017.02.010","article-title":"Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats","volume":"89","author":"Sokar","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2022.01.005_bib0340","first-page":"304","article-title":"Liver fibrosis: causes and methods of assessment, a review","volume":"53.4","author":"Toosi","year":"2015","journal-title":"Rom J Intern Med"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0345","first-page":"1655","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"12","key":"10.1016\/j.pharma.2022.01.005_bib0350","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.pharma.2022.01.005_bib0355","series-title":"Annales pharmaceutiques fran\u00e7aises","article-title":"A rapid lc-pda method for the simultaneous quantification of metformin, empagliflozin and linagliptin in pharmaceutical dosage form","author":"Gollu","year":"2021"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0360","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000381643","article-title":"Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium","volume":"24","author":"Mustafa","year":"2015","journal-title":"Med Princ Pract"},{"issue":"9","key":"10.1016\/j.pharma.2022.01.005_bib0365","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2012.10.011","article-title":"Metformin: the hidden chronicles of a magic drug","volume":"24","author":"Mahmood","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0375","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0380","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0385","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PPO.0000000000000103","article-title":"Metformin, an old drug, brings a new era to cancer therapy","volume":"21","author":"He","year":"2015","journal-title":"Cancer J"},{"issue":"4","key":"10.1016\/j.pharma.2022.01.005_bib0390","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.intimp.2012.01.015","article-title":"Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice","volume":"12","author":"Yuan","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.pharma.2022.01.005_bib0395","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.pharma.2022.01.005_bib0400","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.intimp.2016.06.008","article-title":"Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition","volume":"38","author":"Wang","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13098-019-0491-1","article-title":"Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats","volume":"11","author":"Sui","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.pharma.2022.01.005_bib0410","doi-asserted-by":"crossref","first-page":"e3155","DOI":"10.7717\/peerj.3155","article-title":"Metformin ameliorates insulitis in STZ-induced diabetic mice","volume":"5","author":"Jiang","year":"2017","journal-title":"Peer J"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.pharma.2022.01.005_bib0420","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","article-title":"Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood","volume":"135","author":"Yoshioka","year":"1979","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0425","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.pharma.2022.01.005_bib0430","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0435","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide Biol Chem"},{"issue":"July 2017","key":"10.1016\/j.pharma.2022.01.005_bib0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jep.2017.11.015","article-title":"Protective effect of ethyl acetate fraction of Drynaria quercifolia against CCl4 induced rat liver fibrosis via Nrf2\/ARE and NF\u03baB signalling pathway","volume":"216","author":"Anuja","year":"2018","journal-title":"J Ethnopharmacol"},{"issue":"18","key":"10.1016\/j.pharma.2022.01.005_bib0445","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3748\/wjg.v17.i18.2273","article-title":"Management of liver cirrhosis between primary care and specialists","volume":"17","author":"Grattagliano","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.pharma.2022.01.005_bib0450","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies. Biochimica et biophysica acta","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Mol Basis Dis"},{"key":"10.1016\/j.pharma.2022.01.005_bib0455","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.2147\/DDDT.S179876","article-title":"Asiatic acid ameliorates CCI 4-induced liver fibrosis in rats: involvement of Nrf2\/ARE, NF-\u03baB\/I\u03baB\u03b1, and JAKI\/STAT3 signaling pathways","volume":"12","author":"Fan","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0460","doi-asserted-by":"crossref","first-page":"G100","DOI":"10.1152\/ajpgi.00329.2014","article-title":"Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation","volume":"309","author":"Cahova","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.pharma.2022.01.005_bib0465","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2022.01.005_bib0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopen.2017.01.002","article-title":"Liver and metformin: lessons of a fructose diet in mice","volume":"4","author":"Karise","year":"2017","journal-title":"Biochim Open"},{"issue":"9","key":"10.1016\/j.pharma.2022.01.005_bib0475","doi-asserted-by":"crossref","first-page":"e43056","DOI":"10.1371\/journal.pone.0043056","article-title":"Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis","volume":"7","author":"Kita","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0480","first-page":"531","article-title":"Effect of a probiotic and metformin on liver aminotransferases in non-alcoholic steatohepatitis: a double blind randomized clinical trial","volume":"4","author":"Shavakhi","year":"2013","journal-title":"Int J Prev Med"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0485","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.pharma.2022.01.005_bib0490","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2010-2415","article-title":"Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients","volume":"96","author":"Nkontchou","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.pharma.2022.01.005_bib0495","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0500","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1665-2681(19)31570-4","article-title":"Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats","volume":"10","author":"Ahmed","year":"2011","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0505","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/med.20115","article-title":"Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads","volume":"28","author":"Negi","year":"2008","journal-title":"Med Res Rev"},{"issue":"28","key":"10.1016\/j.pharma.2022.01.005_bib0510","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"Sanchez-Valle","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharma.2022.01.005_bib0515","doi-asserted-by":"crossref","first-page":"424813","DOI":"10.1155\/2015\/424813","article-title":"Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis","volume":"2015","author":"Kelleni","year":"2015","journal-title":"J Toxicol"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0520","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1742-7843.2007.00069.x","article-title":"Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes","volume":"100","author":"Kiruthiga","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0525","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0530","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/1735-5362.253359","article-title":"Metformin attenuates oxidative stress and liver damage after bile duct ligation in rats","volume":"14","author":"Sadeghi","year":"2019","journal-title":"Res Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0535","doi-asserted-by":"crossref","first-page":"e8758","DOI":"10.1371\/journal.pone.0008758","article-title":"Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1","volume":"5","author":"Onken","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharma.2022.01.005_bib0540","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11011-014-9632-2","article-title":"Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia","volume":"30","author":"Ashabi","year":"2015","journal-title":"Metab Brain Dis"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0545","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/JOE-15-0409","article-title":"Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis","volume":"229","author":"Xu","year":"2016","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2474-12-113","article-title":"Reversal of TGF-1stimulation of -smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's\u00a0\u2013\u00a0derived fibroblasts","volume":"12","author":"Satish","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.pharma.2022.01.005_bib0555","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2011.05.023","article-title":"The antifibrotic effects of TGF-\u03b21 siRNA on hepatic fibrosis in rats","volume":"409","author":"Lang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.pharma.2022.01.005_bib0560","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/acer.12167","article-title":"TGF-\u03b21 up-regulates the expression of PDGF-\u03b2 receptor mRNA and induces a delayed PI3K-AKT-, and p70S6K-dependent proliferative response in activated hepatic stellate cells","volume":"37","author":"Shah","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0565","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor \u03b2 Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0570","doi-asserted-by":"crossref","first-page":"e0156090","DOI":"10.1371\/journal.pone.0156090","article-title":"Involvement of TGF-\u03b21\/Smad3 signaling in carbon tetrachloride-induced acute liver injury in mice","volume":"11","author":"Niu","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15171\/jrip.2018.02","article-title":"Metformin; a mini-review to its antioxidative and anti-inflammatory properties","volume":"7","author":"Abbaszadeh","year":"2018","journal-title":"J Renal Injury Prev"},{"issue":"4","key":"10.1016\/j.pharma.2022.01.005_bib0580","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000374096","article-title":"Pathophysiology of liver fibrosis","volume":"33","author":"Pinzani","year":"2015","journal-title":"Dig Dis"},{"issue":"12","key":"10.1016\/j.pharma.2022.01.005_bib0585","doi-asserted-by":"crossref","first-page":"e0144509","DOI":"10.1371\/journal.pone.0144509","article-title":"Free radical-scavenging, anti-inflammatory\/anti-fibrotic and hepatoprotective actions of taurine and silymarin against CCl4 induced rat liver damage","volume":"10","author":"Abdel-Moneim","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharma.2022.01.005_bib0590","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-3305-5-9","article-title":"Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis","volume":"5","author":"El-Lakkany","year":"2012","journal-title":"Parasites Vectors"},{"issue":"12","key":"10.1016\/j.pharma.2022.01.005_bib0595","first-page":"1383","article-title":"Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts","volume":"47","author":"Fuchs","year":"1997","journal-title":"Arzneimittel-Forschung Drug Res"},{"issue":"2","key":"10.1016\/j.pharma.2022.01.005_bib0600","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0676.1991.tb00499.x","article-title":"Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis","volume":"11","author":"Nouchi","year":"1991","journal-title":"Liver"},{"issue":"5","key":"10.1016\/j.pharma.2022.01.005_bib0605","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20425","article-title":"Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats","volume":"40","author":"Parsons","year":"2004","journal-title":"Hepatology"},{"issue":"2\u20133","key":"10.1016\/j.pharma.2022.01.005_bib0610","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2009.07.015","article-title":"(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFR\u03b2 and IGF-1R","volume":"182","author":"Yasuda","year":"2009","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.pharma.2022.01.005_bib0615","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jmf.2013.0179","article-title":"Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4-treated rats","volume":"18","author":"Clichici","year":"2015","journal-title":"J Med Food"},{"issue":"7","key":"10.1016\/j.pharma.2022.01.005_bib0620","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jsfa.4723","article-title":"Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis","volume":"92","author":"Chen","year":"2012","journal-title":"J Sci Food Agric"},{"issue":"7","key":"10.1016\/j.pharma.2022.01.005_bib0625","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3748\/wjg.v24.i7.819","article-title":"Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating amp-activated protein kinase","volume":"24","author":"Li","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.pharma.2022.01.005_bib0630","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1590\/S1516-891320150232","article-title":"Assessment of the potential role of silymarin alone or in combination with vitamin E and\/or curcumin on the carbon tetrachloride induced liver injury in rat","volume":"58","author":"Al-Rasheed","year":"2015","journal-title":"Braz Arch Biol Technol"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:36:01Z","timestamp":1757720161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450922000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0003450922000037"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2022.01.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}